Alpha 2.0

» Articles » PMID: 37670950

Protein Tyrosine Phosphatase Non-receptor Type 2 As the Therapeutic Target of Atherosclerotic Diseases: Past, Present and Future

Overview

Overview

Journal Front Pharmacol

Date 2023 Sep 6

PMID 37670950

Authors

Authors

Xiao-Er Tang

Ya-Qiong Cheng

Chao-Ke Tang

Affiliations

Affiliations

Soon will be listed here.

Abstract

Tyrosine-protein phosphatase non-receptor type 2(PTPN2), an important member of the protein tyrosine phosphatase family, can regulate various signaling pathways and biological processes by dephosphorylating receptor protein tyrosine kinases. Accumulating evidence has demonstrated that PTPN2 is involved in the occurrence and development of atherosclerotic cardiovascular disease. Recently, it has been reported that PTPN2 exerts an anti-atherosclerotic effect by regulating vascular endothelial injury, monocyte proliferation and migration, macrophage polarization, T cell polarization, autophagy, pyroptosis, and insulin resistance. In this review, we summarize the latest findings on the role of PTPN2 in the pathogenesis of atherosclerosis to provide a rationale for better future research and therapeutic interventions.

References

1.

Tang X, Sui X, Liu Y . Immune checkpoint PTPN2 predicts prognosis and immunotherapy response in human cancers. Heliyon. 2023; 9(1):e12873. PMC: 9852697. DOI: 10.1016/j.heliyon.2023.e12873. View

2.

Opoku E, Traughber C, Zhang D, Iacano A, Khan M, Han J . Gasdermin D Mediates Inflammation-Induced Defects in Reverse Cholesterol Transport and Promotes Atherosclerosis. Front Cell Dev Biol. 2021; 9:715211. PMC: 8355565. DOI: 10.3389/fcell.2021.715211. View

3.

Chen L, Zhang Y, Shu X, Chen Q, Wei T, Wang H . Proteasome regulation by reversible tyrosine phosphorylation at the membrane. Oncogene. 2021; 40(11):1942-1956. PMC: 7990385. DOI: 10.1038/s41388-021-01674-z. View

4.

Barquera S, Pedroza-Tobias A, Medina C, Hernandez-Barrera L, Bibbins-Domingo K, Lozano R . Global Overview of the Epidemiology of Atherosclerotic Cardiovascular Disease. Arch Med Res. 2015; 46(5):328-38. DOI: 10.1016/j.arcmed.2015.06.006. View

5.

Ren K, Jiang T, Zhou H, Liang Y, Zhao G . Apigenin Retards Atherogenesis by Promoting ABCA1-Mediated Cholesterol Efflux and Suppressing Inflammation. Cell Physiol Biochem. 2018; 47(5):2170-2184. DOI: 10.1159/000491528. View

6.

Nian Q, Berthelet J, Parlato M, Mechaly A, Liu R, Dupret J . Structural characterization of a pathogenic mutant of human protein tyrosine phosphatase PTPN2 (Cys216Gly) that causes very early onset autoimmune enteropathy. Protein Sci. 2021; 31(2):538-544. PMC: 8820110. DOI: 10.1002/pro.4246. View

7.

Lorenzen J, Dadabay C, FISCHER E . COOH-terminal sequence motifs target the T cell protein tyrosine phosphatase to the ER and nucleus. J Cell Biol. 1995; 131(3):631-43. PMC: 2120615. DOI: 10.1083/jcb.131.3.631. View

8.

Abbas A, Trotta E, Simeonov D, Marson A, Bluestone J . Revisiting IL-2: Biology and therapeutic prospects. Sci Immunol. 2018; 3(25). DOI: 10.1126/sciimmunol.aat1482. View

9.

Spalinger M, Crawford M, Bobardt S, Li J, Sayoc-Becerra A, Santos A . Loss of protein tyrosine phosphatase non-receptor type 2 reduces IL-4-driven alternative macrophage activation. Mucosal Immunol. 2021; 15(1):74-83. PMC: 8732276. DOI: 10.1038/s41385-021-00441-3. View

10.

Ali A, Makings J, Ley K . Regulatory T Cell Stability and Plasticity in Atherosclerosis. Cells. 2020; 9(12). PMC: 7764358. DOI: 10.3390/cells9122665. View

11.

Wang Y, Wu X, Jia T, Feng Y, Liu S, Xu X . Effect of type 2 diabetes mellitus on mandibular bone regeneration and the expression of T helper cell 17/regulat-ory T cell-related factors in mice. Hua Xi Kou Qiang Yi Xue Za Zhi. 2021; 39(6):642-650. PMC: 8703102. DOI: 10.7518/hxkq.2021.06.004. View

12.

Moron B, Spalinger M, Kasper S, Atrott K, Frey-Wagner I, Fried M . Activation of protein tyrosine phosphatase non-receptor type 2 by spermidine exerts anti-inflammatory effects in human THP-1 monocytes and in a mouse model of acute colitis. PLoS One. 2013; 8(9):e73703. PMC: 3767590. DOI: 10.1371/journal.pone.0073703. View

13.

Zhang J, Ma C, Hua Y, Li L, Ni J, Huang Y . Contradictory regulation of macrophages on atherosclerosis based on polarization, death and autophagy. Life Sci. 2021; 276:118957. DOI: 10.1016/j.lfs.2020.118957. View

14.

Spalinger M, Kasper S, Chassard C, Raselli T, Frey-Wagner I, Gottier C . PTPN2 controls differentiation of CD4⁺ T cells and limits intestinal inflammation and intestinal dysbiosis. Mucosal Immunol. 2014; 8(4):918-29. DOI: 10.1038/mi.2014.122. View

15.

Zhu Y, Duan X, Cheng Y, Yao X, Xu H, Zhang K . Evaluation of differential serum expression of three factors and pulmonary function in patients with silicosis. Int J Occup Med Environ Health. 2021; 34(4):527-540. DOI: 10.13075/ijomeh.1896.01644. View

16.

Spalinger M, Sayoc-Becerra A, Ordookhanian C, Canale V, Santos A, King S . The JAK Inhibitor Tofacitinib Rescues Intestinal Barrier Defects Caused by Disrupted Epithelial-macrophage Interactions. J Crohns Colitis. 2020; 15(3):471-484. PMC: 7944512. DOI: 10.1093/ecco-jcc/jjaa182. View

17.

Scharl M, Wojtal K, Becker H, Fischbeck A, Frei P, Arikkat J . Protein tyrosine phosphatase nonreceptor type 2 regulates autophagosome formation in human intestinal cells. Inflamm Bowel Dis. 2011; 18(7):1287-302. DOI: 10.1002/ibd.21891. View

18.

Sakaguchi A, Sylvia V, Martinez L, Smith E, Han E, Lalley P . Assignment of tyrosine-specific T-cell phosphatase to conserved syntenic groups on human chromosome 18 and mouse chromosome 18. Genomics. 1992; 12(1):151-4. DOI: 10.1016/0888-7543(92)90418-r. View

19.

Gao J, Hu J, Li P, Che K, Wang F, Yan S . Human umbilical cord mesenchymal stem cells alleviate the imbalance of CD4 T cells via protein tyrosine phosphatase non-receptor type 2/signal transducer and activator of transcription 3 signaling in ameliorating experimental autoimmune thyroiditis.... Endocr J. 2022; 69(6):613-625. DOI: 10.1507/endocrj.EJ20-0695. View

20.

Zhu Y, Yao J, Duan Y, Xu H, Cheng Q, Gao X . Protein Expression Profile in Rat Silicosis Model Reveals Upregulation of PTPN2 and Its Inhibitory Effect on Epithelial-Mesenchymal Transition by Dephosphorylation of STAT3. Int J Mol Sci. 2020; 21(4). PMC: 7072761. DOI: 10.3390/ijms21041189. View